U.S. market Closed. Opens in 11 hours 19 minutes

CYCN | Cyclerion Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/A297.00K3.32M2.30M4.51MN/AN/A
Cost of RevenueN/A65.00K472.00KN/AN/AN/AN/A
Gross ProfitN/A232.00K2.85M2.30M4.51MN/AN/A
Operating Expenses9.65M44.67M57.63M85.23M129.54M115.25M93.92M
Selling, General & Admin8.13M14.50M20.62M28.82M34.40M27.54M15.12M
Research & Development1.51M31.49M37.64M56.41M95.14M87.72M78.80M
Other Operating ExpensesN/A-1.33M-622.00KN/AN/AN/AN/A
Operating Income-9.65M-44.37M-55.20M-81.27M-125.04M-115.25M-93.92M
Other Expenses / Income-2.95M294.00K3.55M3.46M2.03MN/AN/A
Before Tax Income-12.59M-44.08M-51.65M-77.80M-123.01M-115.25M-93.92M
Income Tax Expenses8.42M-294.00K16.00K-5.13M-2.03MN/AN/A
Net Income-21.02M-43.78M-51.66M-72.67M-120.98M-115.25M-93.92M
Interest ExpensesN/A294.00K16.00KN/AN/AN/AN/A
Basic Shares Outstanding2.34M2.17M1.96M1.52M1.37M1.37M27.30M
Diluted Shares Outstanding2.34M2.17M1.96M1.52M1.37M1.37M27.30M
EBITDA-9.65M-44.31M-53.84M-85.18M-122.34M-113.72M-92.18M
EBITDA Margin0.00%-14,918.18%-1,621.75%-3,709.97%-2,714.38%0.00%0.00%
EBIT-12.59M-43.78M-51.63M-77.80M-123.01M-115.25M-93.92M
EBIT Margin0.00%-14,742.09%-1,555.15%-3,388.59%-2,729.27%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙